Le Lézard
Classified in: Health
Subject: FEA

Implantica achieves regulatory authorisation for RefluxStoptm in New Zealand


STOCKHOLM, June 24, 2021 /PRNewswire/ -- Implantica AG (publ) today announces that RefluxStoptm has been granted marketing authorisation from the New Zealand Medicines and Medical Devices Safety Authority (Medsafe).

RefluxStoptm is a clinically proven treatment for acid reflux that treats the cause of the disease, allowing a natural physiological function of the lower esophageal sphincter (LES) without affecting the food passageway.

Peter Forsell, CEO of Implantica said, "Achieving market authorisation in New Zealand is another step in our regulatory strategy. We are looking forward to commercializing RefluxStoptm in New Zealand. We are currently in discussions with potential distributors to assist us in bringing this novel anti-reflux treatment to surgeons in New Zealand and Australia."

For further information, please contact:

Nicole Pehrsson, Investor Relations

Telephone (CH): +41 (0)79 335 09 49

[email protected]

Implantica is listed on Nasdaq First North Premier Growth Market in Stockholm.

The company's Certified Adviser is FNCA Sweden AB, +46 (0)8 528 00 399, [email protected]

The information was sent for publication, through the agency of the contact person set out above, on June 24, 2021 at 08:30 a.m. CET.

About Implantica

Implantica is a medtech group dedicated to bringing advanced technology into the body. Implantica's lead product, RefluxStoptm, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results. Implantica also focuses on eHealth inside the body and has developed a broad, patent protected, product pipeline based partly on two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body and communicate to the caregiver on distance and a wireless energising platform designed to power remote controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com for further information.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/implantica/r/implantica-achieves-regulatory-authorisation-for-refluxstop--in-new-zealand,c3373585

The following files are available for download:

https://mb.cision.com/Main/19732/3373585/1436414.pdf

Implantica achieves regulatory authorisation for RefluxStopâ?¢ in New Zealand

 


These press releases may also interest you

at 12:46
Bringing peace of mind to patients needing spine surgery, an ultra-minimally invasive procedure called endoscopic spine surgery (ESS) is now being performed in Chicago by Dr. Kern Singh of Midwest Orthopaedics at RUSH, a pioneer in the use of this...

at 12:45
The Joint Commission's Maternal Levels of Care (MLC) Verification program, offered in collaboration with the American College of Obstetricians and Gynecologists (ACOG), has named Grady Health System as a Level IV maternal care verified facility. ...

at 12:45
Detect-ION, with support from the Bill & Melinda Gates Foundation, will apply its cutting-edge breath diagnostic technology in low- and middle-income countries (LMICs), further driving its vision to develop and apply mass spectrometry for the masses....

at 12:37
Steer Health, the leader in AI-powered healthcare automation, announced today that it has successfully completed SOC 2 Type II compliance under the American Institute of Certified Public Accountants (AICPA) Standards for SOC for Service...

at 12:37
While it's been four years since the Covid-19 pandemic disrupted lives, one behavior has left a lasting impression: handwashing. That's based on survey findings of more than 1,000 American adults conducted by Bradley Company, a global manufacturer of...

at 12:31
Starlight Children's Foundation is pleased to announce the launch of its Mental Health Awareness Month campaign, aimed at raising funds and spreading awareness of how Starlight's play-centered programs help improve pediatric patients' mental and...



News published on and distributed by: